Found 73 matching trials
Clinical Trial of Protective Efficacy of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris) PHASE3 The purpose of the research is to evaluate the protective efficacy, immunog...
Show More Status
Active Not Recruiting
Location
Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention
Learn More & Join Trial
Safety and Immunogenicity of Clade C ALVAC and gp120 HIV Vaccine PHASE1 The purpose of this study is to evaluate the safety and immune response to ...
Show More Location
Polana Canico Health Research and Training Center (CISPOC), National Institute of Health (INS) CRS
Learn More & Join Trial
Laser Meridian Massage in Heroin Addicts NA A case-controlled study is conducted to investigate the effect of adjuvant ...
Show More Location
Kaohsiung Chang Gung Memorial Hospital
Learn More & Join Trial
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V114 Followed by PNEUMOVAXâ˘23 in Adults Infected With Human Immunodeficiency Virus (HIV) (V114-018) PHASE3 This study is designed to 1) describe the safety, tolerability, and immunog...
Show More Location
Bliss Healthcare Services ( Site 0010)
Learn More & Join Trial
Phaseâ
Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine EARLY_PHASE1 In the treatment of pneumococcal diseases, the common use of penicillin-bas...
Show More Location
Jiangsu Provincial Center for Diseases Control and Prevention
Learn More & Join Trial
Dose, Safety, Tolerability, and Immunogenicity of an HIV-1 Vaccine, VRC-HIVRGP096-00-VP, With Alum in Healthy Adults PHASE1 Background:
HIV stands for human immunodeficiency virus, which is the viru...
Show More Location
National Institutes of Health Clinical Center
Learn More & Join Trial
H5 Adult - Chiron Study of Bird Flu Vaccine PHASE1 This study is will gather critical information on the safety, tolerability,...
Show More Location
Stanford University
Learn More & Join Trial
Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED) PHASE2 This study was conducted in 2 parts. Part A was a randomized, double-blind,...
Show More Location
Multiple Locations
Learn More & Join Trial
Safety and Immunogenicity of a 10 Valent Pneumococcal Conjugate Vaccine (SIILPCV10) in Healthy Adults, Toddlers, Infants PHASE1 Phase 1/2, Prospective, Single Center, Randomized, ActiveControlled, Double...
Show More Location
Medical Research Council (MRC) Unit, The Gambia
Learn More & Join Trial
Safety, Tolerability, and Immunogenicity of a 3-dose Regimen of V114 in Healthy Infants (PNEU-PED-EU-2/V114-026) PHASE3 The purpose of this clinical study is to evaluate the safety and immunogeni...
Show More Location
Hvidovre Hospital ( Site 0003)
Learn More & Join Trial